2016 SECIM P&F Projects
In 2016, SECIM awarded pilot & feasibility project funds to the following researchers:
- Dr. Sarah Borengasser, University of Colorado at Denver
“Targeted Metabolomics for 1C Metabolites from Maternal Dried Blood Spot Samples
Prior to and During Pregnancy” - Dr. Fernando Bril, University of Florida
“Identification of Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver
Disease” - Dr. Hans Ghayee, University of Florida
“Metabolic Analysis of Human PCC/PGL Cancer Cells Reveals the Importance of
Chromogranin-mediated Deacidification in Cancer Survival” - Dr. John Hartman, University of Alabama at Birmingham
“Integration of genetic and metabolic networks that influence cellular aging” - Dr. Julie Johnson, University of Florida
“Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics” - Dr. Peter Kanetsky, Moffitt Cancer Center
“Metabolomics of Cutaneous Malignant Melanoma” - Dr. Hendrik Luesch, University of Florida
“The functional interplay of marine natural products: marine cyanobacterial small molecules
as activators of secondary metabolism in marine actinobacteria” - Dr. Luke Norton, University of Texas Health Science Center at San Antonio
“The Regulation of Hepatic Pyruvate Metabolism by Pioglitazone” - Dr. Christina Pacak, University of Florida
“Human Urinary Renal Epithelial Cells as Metabolic Biomarkers for Barth Syndrome” - Dr. Mohan Raizada, University of Florida
“Discovery of an Unique Bacterial Metabolic Profile in Resistant Hypertensive Patients” - Dr. Stephanie Wohlgemuth, University of Florida
“Effect of early gestational heat stress on the skeletal muscle metabolome in dairy cows”